Clinical Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Oct 28, 2008; 14(40): 6171-6179
Published online Oct 28, 2008. doi: 10.3748/wjg.14.6171
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Fecal E1 test (μg/g feces) in patients with ACP, ALC or ASA. Reference lines for altered E1: < 200 μg/g, and severely altered E1: < 100 μg/g. ACP vs ALC, P < 0.001; ACP vs ASA, P < 0.001; ALC vs ASA, P = 0.747.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 PDR, %/min of ICG in patients with ACP, ALC or ASA. Reference lines for altered PDR: < 15%/min, and severely altered PDR: < 10%/min. ACP vs ALC, P < 0.001; ACP vs ASA, P = 0.048; ALC vs ASA, P < 0.001.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 An inverse correlation (r = -0. 746, P < 0.001) between indocyanine clearance (PDR, %/min) and fecal E1 test (μg/g feces) in patients with ACP, ALC or ASA. Reference lines: PDR (%/min) = 15; E1 test = 100. Vertical line for PDR (%/min) = 10, and horizontal line for E1 test = 100 are marked in the figure.